anti-obinutuzumab antibodies in patients with membranous nephropathy after obinutuzumab treatment (ChiCTR) - Oct 16, 2026 - P=N/A | N=100 | Not yet recruiting | Sponsor: Huashan Hospital, Fudan University; Huashan Hospital, Fudan University
New trial • Glomerulonephritis • Renal Disease
|